pharmaphorum March 6, 2025
Nicole Raleigh

It takes around seven years to develop a new drug and bring it to market. With the advent of GenAI, businesses in the life sciences sector can speed up the process, wiping months or even years off that average.

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Bryan Hill, life sciences chief technology officer at Cognizant, in a conversation on how generative AI is revolutionising life sciences and drug development.

Though it might seem an obvious...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
The AI Leadership Crisis: Why Chief AI Officers Are Failing (And How To Fix It)
HIMSS25 Tackles AI, Cybersecurity and Workforce Readiness Amid Regulatory Uncertainty
Health Systems Want Deep Guidance from Their Vendors When it Comes to AI, KLAS Finds
"Humans in the loop" make AI work — for now
How AI is revolutionizing cardiology in underserved communities

Share This Article